Efficacy of GLP-1RA according to Type 2 Diabetes Phenotypes-A Monocentric Retrospective Study

被引:0
|
作者
Caruso, Irene
Giordano, Fiorella
Di Gioia, Ludovico
Matichecchia, Immacolata I.
Cignarelli, Angelo
Sorice, Gian Pio
Perrini, Sebastio
Natalicchio, Annalisa
Laviola, Luigi
Giorgino, Francesco
机构
关键词
D O I
10.2337/db24-783-P
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
783-P
引用
收藏
页数:2
相关论文
共 50 条
  • [1] LONG-TERM HEPATOPROTECTIVE EFFECTS OF GLP-1RA IN OBESE PATIENTS WITH TYPE 2 DIABETES: A RETROSPECTIVE COHORT STUDY
    Khataniar, Himsikhar
    Dharia, Ashni
    Desai, Aakash
    Butt, Muhammad Ali
    Babich, Michael
    Mohy-ud-din, Nabeeha
    HEPATOLOGY, 2024, 80
  • [2] Efficacy of HbA1c Changes, Weight Changes, and Blood Pressure Changes in GLP-1RA Daily Treatment or GLP-1RA Weekly Treatment in Type 2 Diabetes
    Cai, Xiaoling
    Yang, Wenjia
    Zhang, Simin
    Ji, Linong
    DIABETES, 2019, 68
  • [3] Finerenone in patients across the spectrum of CKD and type 2 diabetes by GLP-1RA use
    Caramori, M. L.
    Rossing, P.
    Anker, S.
    Filippatos, G.
    Pitt, B.
    Fonseca, V.
    Umpierrez, G. E.
    Lambelet, M.
    Viswanathan, P.
    Lawatscheck, R.
    Joseph, A.
    Bakris, G.
    DIABETOLOGIA, 2022, 65 (SUPPL 1) : S304 - S304
  • [4] Disparities in GLP-1RA Prescription Among a Registry of Patients With Type 2 Diabetes and ASCVD
    Kashyap, Sangeeta
    Avanetti, Eleonora
    Gullapelli, Rakesh
    Nasir, Khurram
    Sadhu, Archana
    OBESITY, 2024, 32 : 151 - 151
  • [5] The comparative effects of metabolic surgery, SGLT2i, or GLP-1RA in patients with obesity and type 2 diabetes: a retrospective cohort study
    Wu, Tingting
    Wong, Carlos K. H.
    Tang, Eric H. M.
    Man, Kenneth K. C.
    Wong, Simon K. H.
    Au, Ivan Chi Ho
    Tse, Emily T. Y.
    Chan, Esther W. Y.
    Grieve, Eleanor
    Wu, Olivia
    Ng, Enders K. W.
    Wong, Ian C. K.
    SURGERY FOR OBESITY AND RELATED DISEASES, 2022, 18 (06) : 762 - 771
  • [6] Cardiovascular benefits of GLP-1RA and SGLT-2i in women with type 2 diabetes
    Mishriky, Basem M.
    Cummings, Doyle M.
    Powell, James R.
    PRIMARY CARE DIABETES, 2022, 16 (03) : 471 - 473
  • [7] CLINICAL IMPACT OF GLP-1RA ON ENDOSCOPY: A RETROSPECTIVE COHORT STUDY IN ENDOSCOPY PATIENTS
    Karlson, Rebecca
    Clukey, Jenna
    Beck, Victoria
    Ziyang, Jonathan Kuang
    Corradini, Giulia Maria
    Dekel, Mia
    Lojacono, Giulia
    Somlo, Diane
    Bar, Nir
    Hobai, Ion
    Kuo, Braden
    GASTROENTEROLOGY, 2024, 166 (05) : S1197 - S1197
  • [8] Clinical Impact of GLP-1RA On Endoscopy: A Retrospective Cohort Study in Endoscopy Patients
    Karlson, Rebecca
    Clukey, Jenna
    Beck, Victoria
    Ziyang, Jonathan Kuang
    Corradini, Giulia Maria
    Dekel, Mia
    Lojacono, Giulia
    Nuako, Akua
    Peterson, Blythe
    Somlo, Diane
    Bar, Nir
    Hobai, Ion
    Kuo, Braden
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S598 - S599
  • [9] Basal insulin intensification with GLP-1RA and dual GIP and GLP-1RA in patients with uncontrolled type 2 diabetes mellitus: A rapid review of randomized controlled trials and meta-analysis
    Lisco, Giuseppe
    De Tullio, Anna
    Disoteo, Olga
    De Geronimo, Vincenzo
    Piazzolla, Giuseppina
    De Pergola, Giovanni
    Giagulli, Vito Angelo
    Jirillo, Emilio
    Guastamacchia, Edoardo
    Sabba, Carlo
    Triggiani, Vincenzo
    FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [10] Health Care Utilization and Cost with Empagliflozin vs. GLP-1RA in Patients with Type 2 Diabetes
    Htoo, Phyo T.
    Tesfaye, Helen
    Wexler, Deborah J.
    Glynn, Robert
    Schmedt, Niklas
    Koeneman, Lisette
    Paik, Julie M.
    Patorno, Elisabetta
    DIABETES, 2024, 73